Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VII

Journal of Orthopaedic Research

Volumn 28, Issue 5, 2010, Pages 616-622

  Smith, Lachlan J ^a   Martin, John T ^a   Szczesny, Spencer E ^a   Ponder, Katherine P ^b   Haskins, Mark E ^c   Elliott, Dawn M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lumbar spine; Mechanical properties; Mucopolysaccharidosis VII; Spinal deformity

Indexed keywords

CALCIUM; GLYCOSAMINOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANNULUS FIBROSUS; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; BONE LESION; BONE MATRIX; BONE RADIOGRAPHY; BONE STRUCTURE; CARTILAGE; CELL FUNCTION; CHEMICAL ANALYSIS; CONTROLLED STUDY; EPIPHYSIS; HISTOPATHOLOGY; IMAGE QUALITY; LUMBAR SPINE; MORPHOLOGY; MUCOPOLYSACCHARIDOSIS TYPE 7; NERVE ENDING; NONHUMAN; NUCLEUS PULPOSUS; PHENOTYPE; PRIORITY JOURNAL; RANGE OF MOTION; RIGIDITY; STAINING; TENSILE STRENGTH; VERTEBRA BODY; WATER CONTENT; WEAKNESS;

ANIMALS; BIOMECHANICS; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOGS; GLYCOSAMINOGLYCANS; HUMANS; INTERVERTEBRAL DISK; LUMBAR VERTEBRAE; MUCOPOLYSACCHARIDOSIS VII; STRESS, MECHANICAL; TENSILE STRENGTH; WATER; WEIGHT-BEARING;

EID: 77949801547     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21030     Document Type: Article

References (32)

1. Sly WS, Quinton BA, McAlister WH, et al. 1973. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 82:249-257.
2. Herati RS, Knox VW, O'Donnell P, et al. 2008. Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy. Mol Genet Metab 95:142-151.
3. Beaudet AL, DiFerrante NM, Ferry GD, et al. 1975. Variation in the phenotypic expression of beta-glucuronidase deficiency. J Pediatr 86:388-394.
4. Vogler C, Levy B, Kyle JW, et al. 1994. Mucopolysaccharidosis VII: postmortem biochemical and pathological findings in a young adult with beta-glucuronidase deficiency. Mod Pathol 7:132-137.
5. Vogler C, Birkenmeier EH, Sly WS, et al. 1990. A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice. Am J Pathol 136:207-217.
6. Haskins ME, Desnick RJ, DiFerrante N, et al. 1984. Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII. Pediatr Res 18:980-984.
7. Vogler C, Levy B, Galvin N, et al. 2005. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse. Pediatr Dev Pathol 8:453-462.
8. Donsante A, Levy B, Vogler C, et al. 2007. Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII. J Inherit Metab Dis 30:227-238.
9. Birkenmeier EH, Davisson MT, Beamer WG, et al. 1989. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J Clin Invest 83:1258-1266.
10. Simonaro CM, D'Angelo M, He X, et al. 2008. Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol 172:112-122.
11. Gitzelmann R, Bosshard NU, Superti-Furga A, et al. 1994. Feline mucopolysaccharidosis VII due to beta-glucuronidase deficiency. Vet Pathol 31:435-443.
12. Fyfe JC, Kurzhals RL, Lassaline ME, et al. 1999. Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII. Genomics 58:121-128.
13. Simonaro CM, D'Angelo M, Haskins ME, et al. 2005. Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res 57:701-707.
14. Haskins M, Casal M, Ellinwood NM, et al. 2002. Animal models for mucopolysaccharidoses and their clinical relevance. Acta Paediatr Suppl 91:88-97.
15. Johannessen W, Vresilovic EJ, Wright AC, et al. 2004. Intervertebral disc mechanics are restored following cyclic loading and unloaded recovery. Ann Biomed Eng 32:70-76.
16. Beckstein JC, Sen S, Schaer TP, et al. 2008. Comparison of animal discs used in disc research to human lumbar disc: axial compression mechanics and glycosaminoglycan content. Spine 33:E166-E173.
17. O'Connell GD, Vresilovic EJ, Elliott DM. 2007. Comparison of animals used in disc research to human lumbar disc geometry. Spine 32:328-333.
18. Ansorge HL, Beredjiklian PK, Soslowsky LJ. 2009. CD44 deficiency improves healing tendon mechanics and increases matrix and cytokine expression in a mouse patellar tendon injury model. J Orthop Res 10:1386-1391.
19. Lynch HA, Johannessen W, Wu JP, et al. 2003. Effect of fiber orientation and strain rate on the nonlinear uniaxial tensile material properties of tendon. J Biomech Eng 125: 726-731.
20. Farndale RW, Buttle DJ, Barrett AJ. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173-177.
21. Sarkar BC, Chauhan UP. 1967. A new method for determining micro quantities of calcium in biological materials. Anal Biochem 20:155-166.
22. Zimmerman MC, Vuono-Hawkins M, Parsons JR, et al. 1992. The mechanical properties of the canine lumbar disc and motion segment. Spine 17:213-220.
23. Oxland TR, Grant JP, Dvorak MF, et al. 2003. Effects of endplate removal on the structural properties of the lower lumbar vertebral bodies. Spine 28:771-777.
24. Acaroglu ER, Iatridis JC, Setton LA, et al. 1995. Degeneration and aging affect the tensile behavior of human lumbar anulus fibrosus. Spine 20:2690-2701.
25. Ebara S, Iatridis JC, Setton LA, et al. 1996. Tensile properties of nondegenerate human lumbar anulus fibrosus. Spine 21:452-461.
26. Mango RL, Xu L, Sands MS, et al. 2004. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs. Mol Genet Metab 82:4-19.
27. Skrzypiec D, Tarala M, Pollintine P, et al. 2007. When are intervertebral discs stronger than their adjacent vertebrae? Spine 32:2455-2461.
28. Albert AM, Maples WR. 1995. Stages of epiphyseal union for thoracic and lumbar vertebral centra as a method of age determination for teenage and young adult skeletons. J Forensic Sci 40:623-633.
29. Sly WS. 2004. Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice. MO Med 101:100-104.
30. Ponder KP, Haskins ME. 2007. Gene therapy for mucopoly-saccharidosis. Expert Opin Biol Ther 7:1333-1345.
31. Krivit W. 2004. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol 26:119-132.
32. Leboy PS. 2006. Regulating bone growth and development with bone morphogenetic proteins. Ann N Y Acad Sci 1068: 14-18.